Xtrem Biotech
-
DATABASE (95)
-
ARTICLES (44)
Founders Fund is a San Francisco-based VC set up in 2005 that currently has more than $3bn of assets under management. It invests across the tech, aerospace and biotechnology sectors and has been an early backer of some of the most impactful tech companies including Airbnb, Facebook, and SpaceX. It has a key interest in solving major problems such as the opioid crisis in the US.Its recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the July 2021 $80m Series C round of residential real estate platform Sundae. The company has managed over 80 exits including Facebook and Spotify and has made over 500 investments, leading approximately one-third of these.
Founders Fund is a San Francisco-based VC set up in 2005 that currently has more than $3bn of assets under management. It invests across the tech, aerospace and biotechnology sectors and has been an early backer of some of the most impactful tech companies including Airbnb, Facebook, and SpaceX. It has a key interest in solving major problems such as the opioid crisis in the US.Its recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the July 2021 $80m Series C round of residential real estate platform Sundae. The company has managed over 80 exits including Facebook and Spotify and has made over 500 investments, leading approximately one-third of these.
Resorts World is the hospitality-focused subsidiary of the Genting Group, a Malaysian diversified conglomerate with business interests in hospitality and leisure, plantations, property, and biotechnology. Resorts World operates luxury accommodations in various tourist destinations within Malaysia and abroad, such as Singapore, Las Vegas, and Birmingham.
Resorts World is the hospitality-focused subsidiary of the Genting Group, a Malaysian diversified conglomerate with business interests in hospitality and leisure, plantations, property, and biotechnology. Resorts World operates luxury accommodations in various tourist destinations within Malaysia and abroad, such as Singapore, Las Vegas, and Birmingham.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
Xtrem Biotech, an agritech startup from Granada, seeks global expansion
With its research roots in the University of Granada, Xtrem Biotech was named one of the world's most innovative agtech spin-offs by accelerator TERRA Food & AgTech
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Forget solar panels and batteries, Bioo wants to scale soil bioelectricity generation
Improving on NASA’s microbial fuel cell tech, Bioo hopes to boost crop efficiency and transform the way urbanites live, in future green cities powered by plants
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Poliloop: Tackling pollution crisis with plastic-eating bacteria for industrial use
Hungarian biotech Poliloop is closing $2m seed funding for “bacteria cocktail” that breaks down plastic into organic waste quickly, enabling more affordable and eco-friendly waste management
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Future Food Asia by ID Capital: Introducing Asia's agrifood startups to the world
More than a meeting of startups and investors, the conference showcases ID Capital’s investment thesis and Big Ag’s support for agrifood tech in the world’s most populous region
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Sorry, we couldn’t find any matches for “Xtrem Biotech”.
POPULAR DATABASE
